Trial intelligence / Profile preview

Safflower oil–clobetasol for treatment of mild eczema

IRCT20250625066252N1Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of clobetasol in atopic dermatitis (AD), sponsored by Isfahan University of Medical Sciences. Started Jul 2025; status: completed.

02

Drugs

clobetasol
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on IRCT20250625066252N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20250625066252N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call